Development and Validation of a Combined Ferroptosis and Immune Prognostic Classifier for Hepatocellular Carcinoma
Background Immunotherapy and sorafenib exert anti-tumor effects via ferroptosis, but reliable biomarkers for the individual treatment and prognosis prediction of hepatocellular carcinoma (HCC) based on the ferroptosis and immune status remain lacking. Methods Ferroptosis-related genes (FRGs) were id...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Saesneg |
Cyhoeddwyd: |
2020
|
Mynediad Ar-lein: | https://doi.org/10.3389/fcell.2020.596679 https://www.frontiersin.org/articles/10.3389/fcell.2020.596679/pdf |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|